Regeneron in $2.32B deal
Regeneron partners with Parabilis to target 'undruggable' proteins, expanding its research capabilities. The deal is worth $2.32 billion.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.